Dr. Denis Fedorenko, whose name goes hand-in-hand with HSCT therapy in Moscow, Russia, will be speaking out in this column on Thursday, July 7. This follows an exclusive interview he has given me for Multiple Sclerosis News Today.
Stem cell treatment of multiple sclerosis is a major talking point at the moment, with many people going to Moscow or another of the leading clinics to undergo HSCT — properly known as aHSCT (autologous hematopoietic stem cell transplantation).
I am fully aware that certain doubts and controversies remain. The fact that HSCT is not yet formally accepted as a treatment for MS has to be taken into consideration. Still, not being a scientist or doctor but with a wealth of anecdotal evidence from HSCT “veterans,” I am more than happy to say that I accept autologous HSCT, with high-dose chemotherapy, as an effective treatment for multiple sclerosis.
The term “autologous” is used because bone marrow stem cells are harvested from the patient. They are treated and frozen to store them until after chemotherapy has been completed. The cells are then reintroduced into the patient’s blood to reboot the immune system.
Many HSCT patients delighted with Federenko and his team
Many patients who have returned from the A.A. Maximov Center in Moscow, where Dr. Fedorenko is responsible for autoimmune diseases and transplantation, have expressed their delight. And that’s delight with the center and its facilities, with the service they experienced, with the treatment received, with the ongoing improvements in their condition and, of course, with Dr. Fedorenko himself.
Realizing that stem cell therapies generally, and HSCT in particular, are hot topics, I found Dr. Fedorenko more than ready to talk to Multiple Sclerosis News Today.
He states his views clearly and candidly — not like most of the politicians I have interviewed during my long career in journalism.
Every time I asked Dr. Fedorenko a question, I got a straight answer. No messing around, no avoiding the question — just straightforward, honest answers.
And that’s what this column is bringing you tomorrow. Be sure to check it out. I assure you it’s one interview you would hate to miss.
UPDATE: Part 1 of the interview is now published. Read “HSCT Can Cure MS, Top Transplant Doctor Says in Exclusive Interview.”
Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this blog article are not those of Multiple Sclerosis News Today, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to Multiple Sclerosis.